
### [NCIT:C3720](http://purl.obolibrary.org/obo/NCIT_C3720)
**Label:** Anaplastic Large Cell Lymphoma

**Subclasses:** [NCIT:C7208](http://purl.obolibrary.org/obo/NCIT_C7208) (Small Cell Variant Anaplastic Large Cell Lymphoma), [NCIT:C8658](http://purl.obolibrary.org/obo/NCIT_C8658) (Refractory Anaplastic Large Cell Lymphoma), [NCIT:C8659](http://purl.obolibrary.org/obo/NCIT_C8659) (Stage I Anaplastic Large Cell Lymphoma), [NCIT:C115357](http://purl.obolibrary.org/obo/NCIT_C115357) (Recurrent Childhood Anaplastic Large Cell Lymphoma), [NCIT:C5322](http://purl.obolibrary.org/obo/NCIT_C5322) (Central Nervous System Anaplastic Large Cell Lymphoma), [NCIT:C115032](http://purl.obolibrary.org/obo/NCIT_C115032) (Stage IV Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115031](http://purl.obolibrary.org/obo/NCIT_C115031) (Stage III Childhood Anaplastic Large Cell Lymphoma), [NCIT:C115030](http://purl.obolibrary.org/obo/NCIT_C115030) (Stage II Childhood Anaplastic Large Cell Lymphoma), [NCIT:C9471](http://purl.obolibrary.org/obo/NCIT_C9471) (Childhood Systemic Anaplastic Large Cell Lymphoma), [NCIT:C39674](http://purl.obolibrary.org/obo/NCIT_C39674) (Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype), [NCIT:C37196](http://purl.obolibrary.org/obo/NCIT_C37196) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C9250](http://purl.obolibrary.org/obo/NCIT_C9250) (Recurrent Anaplastic Large Cell Lymphoma), [NCIT:C9470](http://purl.obolibrary.org/obo/NCIT_C9470) (Systemic Anaplastic Large Cell Lymphoma), [NCIT:C37195](http://purl.obolibrary.org/obo/NCIT_C37195) (Primary Systemic Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C129599](http://purl.obolibrary.org/obo/NCIT_C129599) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C129598](http://purl.obolibrary.org/obo/NCIT_C129598) (Central Nervous System Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C27366](http://purl.obolibrary.org/obo/NCIT_C27366) (Adult Systemic Anaplastic Large Cell Lymphoma), [NCIT:C27365](http://purl.obolibrary.org/obo/NCIT_C27365) (Adult Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C5636](http://purl.obolibrary.org/obo/NCIT_C5636) (Childhood Anaplastic Large Cell Lymphoma), [NCIT:C27367](http://purl.obolibrary.org/obo/NCIT_C27367) (Adult Anaplastic Large Cell Lymphoma), [NCIT:C115029](http://purl.obolibrary.org/obo/NCIT_C115029) (Stage I Childhood Anaplastic Large Cell Lymphoma), [NCIT:C6860](http://purl.obolibrary.org/obo/NCIT_C6860) (Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C7211](http://purl.obolibrary.org/obo/NCIT_C7211) (Childhood Primary Cutaneous Anaplastic Large Cell Lymphoma), [NCIT:C37194](http://purl.obolibrary.org/obo/NCIT_C37194) (Anaplastic Large Cell Lymphoma, ALK-Negative), [NCIT:C8661](http://purl.obolibrary.org/obo/NCIT_C8661) (Stage III Anaplastic Large Cell Lymphoma), [NCIT:C37193](http://purl.obolibrary.org/obo/NCIT_C37193) (Anaplastic Large Cell Lymphoma, ALK-Positive), [NCIT:C8662](http://purl.obolibrary.org/obo/NCIT_C8662) (Stage IV Anaplastic Large Cell Lymphoma), [NCIT:C8660](http://purl.obolibrary.org/obo/NCIT_C8660) (Stage II Anaplastic Large Cell Lymphoma), 

**Class expressions from DL-Learner:**

- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36824](http://purl.obolibrary.org/obo/NCIT_C36824) (Malignant Epithelial Giant Cell))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36821](http://purl.obolibrary.org/obo/NCIT_C36821) (Malignant Neuroendocrine Large Cell))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C3682](http://purl.obolibrary.org/obo/NCIT_C3682) (Sweat Gland Tubular Carcinoma))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36814](http://purl.obolibrary.org/obo/NCIT_C36814) (Malignant Clear Squamous Cell))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36812](http://purl.obolibrary.org/obo/NCIT_C36812) (Warthin-Finkeldey Polykaryocyte))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36791](http://purl.obolibrary.org/obo/NCIT_C36791) (Keratinizing Malignant Squamous Cell))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36783](http://purl.obolibrary.org/obo/NCIT_C36783) (Malignant Non-Cutaneous Basaloid Cell))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36780](http://purl.obolibrary.org/obo/NCIT_C36780) (Malignant Myoepithelial Cell))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C3678](http://purl.obolibrary.org/obo/NCIT_C3678) (Salivary Gland Basal Cell Adenocarcinoma))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36777](http://purl.obolibrary.org/obo/NCIT_C36777) (Signet Ring Adenocarcinoma Cell))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36775](http://purl.obolibrary.org/obo/NCIT_C36775) (Malignant Spindle Squamous Cell))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36754](http://purl.obolibrary.org/obo/NCIT_C36754) (Paget Cell))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36749](http://purl.obolibrary.org/obo/NCIT_C36749) (Neoplastic Keratinocyte))) 60.82%
- [NCIT:C36446](http://purl.obolibrary.org/obo/NCIT_C36446) (Clonal T-Cell Receptor Gene Rearrangement) and (not ([NCIT:C36742](http://purl.obolibrary.org/obo/NCIT_C36742) (Spider Cell))) 60.82%


